Kala Bio KALA
NASDAQ KALA
$0.56 +0.00 (+0.00%)
As of: Sep 10, 2026 · 2:47 PM EDT

Kala Bio (KALA) Gross Margin (2019 - 2022)

Kala Bio's (KALA) quarterly Gross Margin came in at 97.38% in Q3 2022, up 2699.0% year-over-year from 3.48% in Q3 2021, and up 527.3% quarter-over-quarter from 15.52% in Q2 2022.

Analysis

Kala Bio (KALA) Gross Margin (2019 - 2022) Analysis & Trends

Kala Bio has disclosed Gross Margin across 4 years of filings, most recently posting 97.38% for Q3 2022.

  • In Q3 2022, Gross Margin rose 2699.0% year-over-year to 97.38%; the TTM figure through Dec 2022 stood at 34.22% (down 2933.0% YoY), while the FY2022 annual figure was 34.22%, down 2933.0% from the prior year.
  • Gross Margin came in at 97.38% for Q3 2022 at Kala Bio, up from 15.52% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 97.38% in Q3 2022 to a low of 8.88% in Q2 2020.
  • Average Gross Margin over 4 years is 55.58%, with a median of 66.7% recorded in 2021.
  • Year-over-year, Gross Margin plunged 7400 bps in 2020 and jumped 5782 bps in 2021.
  • Over 4 years, Gross Margin stood at 36.69% in 2019, then increased by 7 bps to 39.28% in 2020, then plunged by 40 bps to 23.6% in 2021, then jumped by 313 bps to 97.38% in 2022.
  • Per Business Quant data, the three most recent Gross Margin figures were 97.38% in Q3 2022, 15.52% in Q2 2022, and 43.51% in Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Amgen 206.55 Bn 192.56 Bn 7.24 Bn 72.04%
2 Gilead Sciences 180.15 Bn 176.98 Bn 6.22 Bn 79.76%
3 Vertex Pharmaceuticals 131.59 Bn 123.73 Bn 2.84 Bn 85.33%
4 Regeneron Pharmaceuticals 81.98 Bn 73.98 Bn 3.93 Bn 91.59%
5 Argenx Se 60.33 Bn 55.14 Bn 1.37 Bn 90.43%
6 Moderna 53.75 Bn 48.61 Bn 52.00 Mn 35.86%
7 Alnylam Pharmaceuticals 33.06 Bn 29.76 Bn 992.69 Mn 76.90%
8 Biogen 31.95 Bn 30.67 Bn 1.96 Bn 71.60%
9 Roivant Sciences 29.25 Bn 29.25 Bn 1.16 Mn 80.31%
10 Kala Bio 8.44 Mn 8.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 97.38%
Jun 30, 2022 15.52%
Mar 31, 2022 43.51%
Dec 31, 2021 23.60%
Sep 30, 2021 70.39%
Jun 30, 2021 66.70%
Mar 31, 2021 76.88%
Dec 31, 2020 39.28%
Sep 30, 2020 68.42%
Jun 30, 2020 8.88%
Mar 31, 2020 66.95%
Dec 31, 2019 36.69%
Sep 30, 2019 53.96%
Jun 30, 2019 82.89%
Mar 31, 2019 82.61%